
Disclosing Genetic Risk of Alzheimer’s Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II)
Author(s) -
Emily A. Largent,
Twisha Bhardwaj,
Maramawit Abera,
Shana D. Stites,
Kristin Harkins,
Alan J. Lerner,
Angela R. Bradbury,
Jason Karlawish
Publication year - 2021
Publication title -
journal of alzheimer's disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.677
H-Index - 139
eISSN - 1875-8908
pISSN - 1387-2877
DOI - 10.3233/jad-210675
Subject(s) - apolipoprotein e , disease , psychology , perception , alzheimer's disease , stigma (botany) , clinical psychology , gerontology , medicine , psychiatry , pathology , neuroscience
Current practice guidelines recommend against Apolipoprotein E (APOE) testing. However, advances in Alzheimer's disease (AD) research and care may soon change this.